Detalhe da pesquisa
1.
Pembrolizumab with R-CHOP in previously untreated diffuse large B-cell lymphoma: potential for biomarker driven therapy.
Br J Haematol
; 189(6): 1119-1126, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030732
2.
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study.
Lancet Haematol
; 8(8): e562-e571, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34329577